Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-16-008977
Filing Date
2016-12-14
Accepted
2016-12-14 15:08:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 c86766_sc13g.htm SC 13G 64828
  Complete submission text file 0000930413-16-008977.txt   66269
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Subject) CIK: 0001166272 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-87783 | Film No.: 162050999
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G